Representation isn’t.
Clinical trials registered globally last year
Black & Hispanic communities make up 31% of the U.S. population but often less than 15% of trial participants
Patients reached through culturally grounded outreach
Up to 30% faster enrollment when representation is built in from day one
The Problem
The clinical trials gap is real — and costly.
More trials. Same participants.
Despite record growth in clinical research, most trials still draw from the same limited demographics.
Communities with the highest need participate the least.
Chronic disease burden is rising fastest in underserved Black, Brown, immigrant, and low-income communities — yet their voices remain underrepresented in medical data.
Sponsors feel the impact.
Under-enrollment delays timelines, increases costs, and weakens real-world relevance.
For Sponsors
Stronger trials. Faster timelines. Real-world relevance.
- Precision recruitment strategies centered on representation
- Messaging written for real communities, not corporate templates
- Local partnerships and grassroots outreach that build trust
- Support from protocol design through last-patient-in
For Patients & Families
Real options. Clear explanations. Support you can trust.
- Learn what a study really involves — in language you understand
- Help with questions, logistics, and next steps
- Access to innovative treatments close to home
- Participation that helps your community long-term
There’s a gap between a protocol and a person.
We bridge it.
Why Outreach
We listen first.
Understanding culture, barriers, and motivations leads to better recruitment.
We partner locally.
Real people, real conversations, real connection — not mass flyers.
We enroll effectively.
Representation-focused strategies that deliver speed and integrity.
Serving sponsors nationwide.
Serving patients at home.
Outreach Clinical Trials specializes in diverse patient recruitment, bridging gaps in access, awareness, and trust.
We accelerate timelines and improve representation — especially for diabetes, obesity, cardiovascular, and metabolic clinical trials across the U.S.